About Aryastha
Aryastha is a company based in Hyderabad (India) founded in 2023 by Raghava Reddy Kethri and Pradip K Majumder. Aryastha has raised $2.13 million across 1 funding round from investors including Vessella. The company has 1 employees as of March 19, 2024. Aryastha offers products and services including Discovery Chemistry, Discovery Biology, Pre-Clinical DMPK, and Development Services. Aryastha operates in a competitive market with competitors including Charles River Laboratories, Cytel, LabCorp, Precision Medicine Group and Frontage Laboratories, among others.
- Headquarter Hyderabad, India
- Employees 1 as on 19 Mar, 2024
- Founders Raghava Reddy Kethri, Pradip K Majumder
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Aryastha Life Sciences Private Limited
- Date of Incorporation 18 Jul, 2023
- Jurisdiction Golconda, Telangana, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.13 M (USD)
in 1 rounds
-
Latest Funding Round
$2.13 M (USD), Series A
Aug 05, 2023
- Investors
-
Employee Count
1
as on Mar 19, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aryastha
Aryastha offers a comprehensive portfolio of products and services, including Discovery Chemistry, Discovery Biology, Pre-Clinical DMPK, and Development Services.
Involves developing new medicines through chemical processes.
Utilizes cell lines and models for drug testing and development.
Evaluates drug metabolism and toxicity in preclinical stages.
Supports scaling from research to production with quality controls.
People of Aryastha
Unlock access to complete
Leadership Team
8 people
Sales and Marketing
1 people
Senior Team
1 people
Group Team
1 people
Unlock access to complete
Funding Insights of Aryastha
Aryastha has successfully raised a total of $2.13M through 1 strategic funding round. The most recent funding activity was a Series A round of $2.13 million completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Aryastha
Aryastha has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Vessella.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Develops innovative technologies for real estate projects.
|
Locked | Locked | Locked |
Investor details for Aryastha
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aryastha
Investment portfolio details for Aryastha
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aryastha
Detailed financials for Aryastha
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aryastha Comparisons
Peer comparison for Aryastha
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aryastha
Aryastha operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Charles River Laboratories, Cytel, LabCorp, Precision Medicine Group and Frontage Laboratories, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of drug discovery and preclinical development services
|
|
| Locked | Locked | Locked |
Data analysis and statistical solutions are provided for life sciences.
|
|
| Locked | Locked | Locked |
Provider of laboratory tests for physicians
|
|
| Locked | Locked | Locked |
Provider of clinical research, development, and commercialization services for life sciences
|
|
| Locked | Locked | Locked |
Early drug development services are provided for pharma firms.
|
|
| Locked | Locked | Locked |
Company offering specialised R&D and clinical development services for the development of precision medicine based drugs and devices
|
Detailed competitors of Aryastha
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aryastha
Complete news archive for Aryastha
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aryastha
Aryastha was founded in 2023.
Aryastha is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Raghava Reddy Kethri is the current CEO of Aryastha. They have also founded this company.
Aryastha is a funded company, having raised a total of $2.13M across 1 funding round to date.
As of Mar 19, 2024, the latest employee count at Aryastha is 1.
Aryastha was founded in 2023 in Hyderabad, India, as a contract research and development entity in the pharmaceutical sector. Services encompass drug discovery, medicinal chemistry, pre-clinical development, toxicology assessments, formulation progression, analytical evaluations, and infrastructure support. Operations are centered on supporting pharmaceutical advancements through specialized expertise and facilities in the region.
Aryastha's top competitors include LabCorp, Charles River Laboratories and Cytel.
Aryastha offers Discovery Chemistry, Discovery Biology, Pre-Clinical DMPK, and Development Services.
Aryastha has 1 investor. Key investors include Vessella.
The valuation of Aryastha is $11.37M as of Aug 2023.